TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics.
TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics.
复制标题
DOI:
10.1053/j.seminhematol.2020.12.002
复制
发表时间:
2021-01
影响因子:
3.6
通讯作者:
Jha BK
中科院分区:
文献类型:
--
作者:
Guan Y;Hasipek M;Tiwari AD;Maciejewski JP;Jha BK
TET2 is one of the most frequently mutated genes in myeloid neoplasms. TET2 loss-of-function perturbs myeloid differentiation and causes clonal expansion. Despite extensive knowledge regarding biochemical mechanisms underlying distorted myeloid differentiation, targeted therapies are lagging. Here we review known biochemical mechanisms and candidate therapies that emerge from this. Specifically, we discuss the potential utility of vitamin C to compensate for TET-dioxygenase deficiency, to thereby restore the biochemical function. An alternative approach exploits the TET-deficient state for synthetic lethality, exploiting the fact that a minimum level of TET-dioxygenase activity is required for cell survival, rendering TET2-mutant malignant cells selectively vulnerable to inhibitors of TET-function.
登录
查看更多内容
影响因子:
11.4
作者:
通讯作者:
--
影响因子:
64.8
作者:
Han, Zhifu;Niu, Tianhui;Chai, Jijie
通讯作者:
Chai, Jijie
DOI:
10.1056/nejmoa1409405
发表时间:
2014-12-25
期刊:
The New England journal of medicine
影响因子:
--
作者:
Genovese G;Kähler AK;Handsaker RE;Lindberg J;Rose SA;Bakhoum SF;Chambert K;Mick E;Neale BM;Fromer M;Purcell SM;Svantesson O;Landén M;Höglund M;Lehmann S;Gabriel SB;Moran JL;Lander ES;Sullivan PF;Sklar P;Grönberg H;Hultman CM;McCarroll SA
通讯作者:
McCarroll SA
影响因子:
21.3
作者:
Etchegaray JP;Chavez L;Huang Y;Ross KN;Choi J;Martinez-Pastor B;Walsh RM;Sommer CA;Lienhard M;Gladden A;Kugel S;Silberman DM;Ramaswamy S;Mostoslavsky G;Hochedlinger K;Goren A;Rao A;Mostoslavsky R
通讯作者:
Mostoslavsky R
影响因子:
64.8
作者:
Agathocleous M;Meacham CE;Burgess RJ;Piskounova E;Zhao Z;Crane GM;Cowin BL;Bruner E;Murphy MM;Chen W;Spangrude GJ;Hu Z;DeBerardinis RJ;Morrison SJ
通讯作者:
Morrison SJ